CBE ID
1522
1.4 Project
Endorsement Status
1.1 New or Maintenance
Previous Endorsement Cycle
Is Under Review
No
1.3 Measure Description
Proportion of ICD implant patients with a diagnosis of LVSD who are prescribed ACE-I or ARB therapy at discharge.
-
-
1.5 Measure Type1.7 Electronic Clinical Quality Measure (eCQM)1.8 Level Of Analysis1.9 Care Setting1.20 Testing Data Sources
-
1.14 Numerator
Count of patients with ACE-I or ARB therapy prescribed at discharge.
-
1.15 Denominator
1) Count of patients with an ICD implant with moderate or severe LVSD (LVEF<40%) who are eligible for ACE inhibitors who do not have a contraindication to ACE inhibitors documented
AND
2)Count of patients with an ICD implant with moderate or severe LVSD (LVEF<40%) who are eligible for ARB therapy who do not have a contraindication to ARB therapy documented
-
Exclusions
Discharge status of expired
Contraindicated or blinded to both ACE inhibitors and ARB therapy
-
Most Recent Endorsement Activity - OLDMeasure Retired and Endorsement Removed Cardiovascular Project 2015-2016Initial EndorsementLast UpdatedRemoval Date
-
StewardAmerican College of CardiologySteward Organization POC EmailSteward Organization Copyright
© 2010 American College of Cardiology Foundation All Rights Reserved
-
-
-
Risk Adjustment
-
-
-
6.1.2 Current or Planned Use(s)
-
Planned Use
-